August 2025

Our lab published “Transformer-Based Deep Learning Approaches for Speech-Based Dementia Detection: A Systematic Review” in the IEEE Journal of Biomedical and Health Informatics on August 6, 2025.

Our lab also published “Autoimmune antibodies and systemic inflammatory markers are prevalent and associated with cognition in individuals aged 90+” in the Journal of Alzheimer’s Disease on August 8, 2025.

IEEE Journal of Biomedical and Health Informatics

CHASE 2025

Our lab presented the poster “Multimodal Deep Learning Approach to Detect Cognitive Impairment in the Oldest-Old with Digital Speech Markers” at the 2025 IEEE/ACM Conference on Connected Health: Applications, Systems and Engineering Technologies (CHASE).

July 2025

ALZHEIMER’S & DEMENTIA PUBLICATION

Our lab published a paper titled “Association of language markers with future cognitive impairment and presence of limbic predominant age related TDP-43 encephalopathy” in the journal Alzheimer’s & Dementia (Volume 21 Issue 7) on July 10, 2025.

*   *   *

AAIC 2025

Our lab presented “Detection of Cognitive Impairment Using Bidirectional Long Short-Term Memory and Speech-Derived Digital Biomarkers in Native English Speakers” at the Alzheimer’s Association International Conference (AAIC) on July 27, 2025.

December 2024

Our lab published multiple papers in the journal Alzheimer’s & Dementia in December 2024, featured in Volume 20 Issues S1, S2, and S3. The papers are listed below:

Alzheimer’s & Dementia, Volume 20, Issue S1 Supplement: Basic Science and Pathogenesis, December 2024

Alzheimer’s & Dementia, Volume 20, Issue S2 Supplement: Biomarkers, December 2024


Alzheimer’s & Dementia, Volume 20, Issue S3 Supplement: Clinical Manifestations, December 2024

November 2024

Our lab published a paper titled “Cerebral perfusion and amyloidosis in the oldest-old” in the journal Alzheimer’s & Dementia (Volume 20 Issue 12) on November 13, 2024.

Additionally, our lab published a paper titled “Pure LATE-NC: Frequency, clinical impact, and the importance of considering APOE genotype when assessing this and other subtypes of non-Alzheimer’s pathologies” in the journal Acta Neuropathologica (Volume 148) on November 15, 2024.

AAIC 2024

Members of our lab (S. Ahmad Sajjadi, Davis Woodworth, Pooyan Mobtahej, Ghasem Farahmand, Lorena Sordo) presented 10 poster presentations at the Alzheimer’s Association International Conference (AAIC) 2024, which took place from July 28th to August 1st. The following posters were presented (presenters are bolded):

 

  • Contribution of neuropathological changes to cognitive decline in late life; The 90+ Study
    • Authors: Jiaxin Yu MS, Davis Woodworth PhD , Syed Bukhari MS , Ali Ezzati MD , Tom Montine MD, PhD , Claudia Kawas MD , Maria Corrada ScD , Tianchen Qian PhD, S. Ahmad Sajjadi MD, PhD (1) University of California, Irvine, Irvine, CA, USA (2) Stanford University, Stanford, USA

 

  • Detection of Cognitive Impairment through Spontaneous Speech Acoustic Markers Using Transformer-based Machine Learning Approach
    • Authors: Pooyan Mobtahej, EngD, Sam Gouron, BS, Annelisse El-Khoury, BS, Anne-Marie C. Leiby, BS, BA, Claudia H. Kawas, MD, Maria M. Corrada, ScM, ScD, and S. Ahmad Sajjadi, MD, PhD (1) School of Medicine, University of California, Irvine, CA, USA

 

  • Asymmetrical hippocampal atrophy: an arrow in the quiver of imaging markers for LATE-NC
    • Authors: Davis C. Woodworth, PhD; Dana E. Greenia, RN, MS; Syed A. Bukhari, MS; Thomas J. Montine, MD, PhD; Ali Ezzati, MD; Claudia H. Kawas, MD; María M. M. Corrada, ScM, ScD and S. Ahmad Sajjadi, MD, PhD (1)University of California, Irvine, Irvine, CA, USA, (2) Stanford University, Stanford, CA, USA

 

  • Evaluating updated LATE-NC staging criteria using National Alzheimer’s Coordinating Center data: stage 1 subtypes matter
    • Authors: Davis C. Woodworth, PhD; Katelynn M. Nguyen, BS, BA; Lorena Sordo, PhD; Kiana A. Scambray, MA; Elizabeth Head, PhD; Claudia H. Kawas, MD; María M. M. Corrada, ScM, ScD; Peter T Nelson, MD, PhD4 and S. Ahmad Sajjadi, MD, PhD, (1) University of California, Irvine, Irvine, CA, USA, (2) The UC Irvine Institute for Memory Impairments and Neurological Disorders (UCI MIND), Irvine, CA, USA, (3) University of Michigan, Ann Arbor, MI, USA, (4) College of Medicine, University of Kentucky, Lexington, KY, USA

 

  • Serological inflammation markers and their association with cognition in the oldest old; The 90+ Study
    • Authors: Anne-Marie C Leiby, BS, BA; Ghasem Farahmand, MD; Aanan Ramanathan, BS; Davis C. Woodworth, PhD; Luohua Jiang, MD, PhD; Jiaxin Yu, MS; Tianchen Qian, PhD; María M. M. Corrada, SCM, ScD; Claudia H. Kawas, MD and S. Ahmad Sajjadi, MD, PhD, (1)University of California, Irvine, CA, USA, (2) University of California, Irvine, Irvine, CA, USA, (3) University of California Irvine, Irvine, CA, USA

 

  • The potential of plasma TDP-43 as a biomarker for limbic predominant age related TDP-43 Encephalopathy
    • Authors: Lorena Sordo, PhD; Anne-Marie C Leiby, BS, BA; Rond Malhas, BS; James Barlow4; Robert A. Rissman, PhD5; Claudia H. Kawas, MD; María M. M. Corrada, ScM, ScD; Elizabeth Head, PhD and S. Ahmad Sajjadi, MD, PhD, (2) University of California, Irvine, CA, USA, (3) University of California, Irvine, Irvine, CA, USA, (4) University of California San Diego, La Jolla, CA, USA, (5) University of California, San Diego, La Jolla, CA, USA

 

  • Transformer-based Deep Learning Architecture Improves Detection of Associations between Spontaneous Speech Language Markers and Cognition
    • Authors: Pooyan Mobtahej, EngD; Sam Gouron, BS; Rojan Javaheri, BS; Annelisse El-Khoury, BS; Anne-Marie C Leiby, BS, BA; David L Sultzer, MD and S. Ahmad Sajjadi, MD, PhD, (1) University of California, Irvine, Irvine, CA, USA, (2) University of California, Irvine, CA, USA, (3) The UC Irvine Institute for Memory Impairments and Neurological Disorders (UCI MIND), Irvine, CA, USA, (4) Institute for Memory Impairments and Neurological Disorders (UCI-MIND), University of California, Irvine, Irvine, CA, USA

 

  • Associations of cerebral amyloid and tau with neurocognitive performance: Findings from the 90+ Study
    • Authors: Evan Fletcher, Ph.D.; Shraddha Sapkota, PhD; Oliver Martinez, BS; María M. M. Corrada, ScM, ScD; Davis C. Woodworth, PhD; S. Ahmad Sajjadi, MD, PhD and Charles Decarli, MD, (1)UC Davis, Davis, CA, USA, (2)University of California, Davis, Davis, CA, USA, (3) University of California, Irvine, Irvine, CA

 

  • A weakly-supervised, MRI-guided clustering of cognitive decline: A post-hoc analysis of the EXPEDITION-3 clinical trial
    • Authors: Bhargav Teja Nallapu, PhD; Kellen K. Petersen, PhD; Idris Demirsoy, PhD; Richard B. Lipton, MD; Christos Davatzikos, PhD; Laura Rabin, PhD4; S. Ahmad Sajjadi, MD, PhD5 and Ali Ezzati, MD6 (1) Albert Einstein College of Medicine, Bronx, NY, USA, (2) University of California, Irvine, Irvine, CA, USA, (3) Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA, (4) Brooklyn College of the City University of New York, Brooklyn, NY, USA, (5) Institute for Memory Impairments and Neurological Disorders (UCI-MIND), University of California, Irvine, Irvine, CA, USA, (6) University of California Irvine, Irvine, CA, USA

 

  • Utility of recruitment incentives in early Alzheimer’s disease clinical trials
    • Authors: Marina Ritchie, MS; Megan G. Witbracht, PhD; Eunji Russ, MA; S. Ahmad Sajjadi, MD, PhD; Gaby Thai, MD; Steven Tam, MD; Daniel L Gillen, PhD and Joshua D Grill, PhD, University of California, Irvine, Irvine, CA, USA